Spots Global Cancer Trial Database for childhood b acute lymphoblastic leukemia

Every month we try and update this database with for childhood b acute lymphoblastic leukemia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia	NCT00437060	Childhood B Acu... Childhood T Acu... Cognitive Side ... Long-Term Effec... Neurotoxicity S... Psychological I... Untreated Child...	Cognitive Asses... Diffusion Tenso... Laboratory Biom... Pharmacological... Psychosocial As...	1 Year - 17 Years	Children's Oncology Group
Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma	NCT01190930	Acute Lymphobla... Adult B Lymphob... Ann Arbor Stage... Ann Arbor Stage... Childhood B Acu... Childhood B Acu... Childhood B Lym... Down Syndrome Hypodiploid B A... Philadelphia Ch...	Cyclophosphamid... Cytarabine Dexamethasone Doxorubicin Hyd... Laboratory Biom... Leucovorin Calc... Mercaptopurine Methotrexate Pegaspargase Quality-of-Life... Questionnaire A... Thioguanine Vincristine Sul...	1 Year - 30 Years	Children's Oncology Group
Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma	NCT01403415	Childhood B Acu... Childhood T Acu... Mature T-Cell a... Recurrent Child... Recurrent Child...	Dexamethasone Laboratory Biom... Methotrexate Mitoxantrone Hy... Pegaspargase Pharmacological... Temsirolimus Vincristine Sul...	1 Year - 21 Years	National Cancer Institute (NCI)
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia	NCT00075725	Acute Lymphobla... Adult B Acute L... Childhood B Acu...	Cyclophosphamid... Cytarabine Daunorubicin Hy... Dexamethasone Doxorubicin Hyd... Leucovorin Calc... Mercaptopurine Methotrexate Pegaspargase Prednisone Radiation Thera... Thioguanine Vincristine Sul...	1 Year - 30 Years	Children's Oncology Group
Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011)	NCT00866307	Acute Lymphobla... Adult B Acute L... Childhood B Acu...	Cyclophosphamid... Cytarabine Daunorubicin Hy... Dexamethasone Doxorubicin Hyd... Laboratory Biom... Mercaptopurine Methotrexate Pegaspargase Prednisone Prophylactic Cr... Thioguanine Vincristine Sul...	1 Year - 30 Years	Children's Oncology Group
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia	NCT00075725	Acute Lymphobla... Adult B Acute L... Childhood B Acu...	Cyclophosphamid... Cytarabine Daunorubicin Hy... Dexamethasone Doxorubicin Hyd... Leucovorin Calc... Mercaptopurine Methotrexate Pegaspargase Prednisone Radiation Thera... Thioguanine Vincristine Sul...	1 Year - 30 Years	Children's Oncology Group
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia	NCT00103285	Acute Lymphobla... Childhood B Acu...	3-Dimensional C... Cyclophosphamid... Cytarabine Dexamethasone Doxorubicin Hyd... Leucovorin Calc... Mercaptopurine Methotrexate Pegaspargase Thioguanine Vincristine Sul...	1 Year - 9 Years	Children's Oncology Group
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia	NCT00075725	Acute Lymphobla... Adult B Acute L... Childhood B Acu...	Cyclophosphamid... Cytarabine Daunorubicin Hy... Dexamethasone Doxorubicin Hyd... Leucovorin Calc... Mercaptopurine Methotrexate Pegaspargase Prednisone Radiation Thera... Thioguanine Vincristine Sul...	1 Year - 30 Years	Children's Oncology Group

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: